Vertical Aerospace 株価情報 (NYSE: EVTL)

最新ニュース Vertical Aerospace (NYSE:EVTL) 株価情報

Vertical Aerospace

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a global aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Vertical Aerospace Ltd

Structure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.80) by 2.5 percent. This is a 3.7 percent increase over losses of $(0.81) per share from the same period last year.

Earnings

News

GPCR

Structure Therapeutics FY 2024 GAAP EPS $(0.78) Beats $(0.80) Estimate

Issuing Initial Annual 2025 Guidance Including Revenue of $13.45 Billion, a 9% Increase Over 2024, GAAP Net Income of $327&nbsp;Million to $366 Million, Adjusted EBITDA of $1.10 Billion to $1.15 Billion, with Diluted Earnings Per Share of $3.75 to $4.24.
 &nbsp;

Guidance

MasTec Expects FY25 Revenue Of $13.45B (Est $13.281B), Adjusted EPS Of $5.35 - $5.84 (Est $5.31)

Arcadium Lithium (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 97.06 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $289.00 million which beat the analyst consensus estimate of $269.06 million by 7.41 percent. This is a 58.79 percent increase over sales of $182.00 million the same period last year.

Earnings Beats

ALTM

CORRECTION: Arcadium Lithium Q4 Adj EPS $0.01, Inline, Sales $289.00M Beat $269.06M Estimate

Nelnet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNI#NYSE">NNI</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.23 by 17.07 percent. &nbsp;

Nelnet Q4 2024 Adj EPS $1.44 Beats $1.23 Estimate

DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.18 by 22.22 percent. This is a 26.32 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $190.62 million which missed the analyst consensus estimate of $196.89 million by 3.18 percent. This is a 10.68 percent increase over sales of $172.23 million the same period last year.

Earnings Misses

DoubleVerify Hldgs Q4 EPS $0.14 Misses $0.18 Estimate, Sales $190.62M Miss $196.89M Estimate

Implores UDF IV Board to Postpone March 4 Special Meeting for One Month to Engage with NexPoint and Appropriately Evaluate Proposal
NexPoint Will Not Vote at Special Meeting Without Due Consideration of Proposal
DALLAS, Feb. 27, 2025 /PRNewswire/ --&nbsp;NexPoint Advisors, L.P. (together with its affiliates "NexPoint") today announced NexPoint Real Estate Opportunities, LLC has submitted a competing proposal to the Board of Trustees of United Development Funding IV ("UDF IV" or "the Trust") ahead of the Special Meeting of UDF IV Shareholders (the "Meeting"), scheduled for&nbsp;March 4, 2025, to vote on the proposed merger of UDF IV with Ready Capital (NYSE:&nbsp;RC) (the "Ready Merger").
The confidential proposal submitted by NexPoint mirrors many elements of the Ready Merger but provides shareholders with superior economic terms, including enhanced balance sheet distributions, full entitlement to Contingent Value Rights ("CVR") loan proceeds, and potentially large indemnification reimbursements. Specifically, NexPoint's offer contemplates balance sheet distributions that it believes will provide shareholders with a higher pre-closing dividend than the Ready Merger. Shareholders would also receive 100% of the net principal and interest recovered on the CVR loans. By comparison, the Ready Merger entitles Ready Capital to 100% of the CVR loan proceeds until it has recovered $13.3 million net, and thereafter shareholders only receive credit for 60% of additional net recoveries, which UDF IV estimates to be as much as $20 million. Additionally, NexPoint proposes to cease further indemnification payments for the imprisoned management team and recipients of the improper indemnity payments associated with the SEC disgorgement and intends to recover those improperly advanced legal fees and indemnity payments, with 100% of net recoveries being distributed to shareholders.

Management

NXDT

NexPoint Urges UDF IV Board To Postpone March 4 Meeting, Calls For 1-Month Delay To Evaluate Superior Proposal; Offers Enhanced Distributions, Full CVR Share, And Indemnity Reimbursement; NexPoint Won't Vote Without Proper Consideration

HTCO

High-Trend International FY24 Total Revenue $108.2M, Up 13.6% YoY

Arcosa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) sees FY2025 sales of $2.800 billion-$3.000 billion vs $2.95 billion analyst estimate.

Arcosa Sees FY2025 Sales $2.800B-$3.000B vs $2.95B Est

Banco Latinoamericano (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLX#NYSE">BLX</a>) reported quarterly earnings of $1.40 per share. This is a 10.24 percent increase over earnings of $1.27 per share from the same period last year. The company reported $78.40 million in sales this quarter. This is a 0.77 percent increase over sales of $77.80 million the same period last year.

Banco Latinoamericano Q4 EPS $1.40 Up From $1.27 YoY, Sales $78.40M Up From $77.80M YoY

Arcosa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.76 by 39.47 percent. This is a 32.35 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $666.20 million which missed the analyst consensus estimate of $690.28 million by 3.49 percent. This is a 14.43 percent increase over sales of $582.20 million the same period last year.

Arcosa Q4 Adj $0.46 Misses $0.76 Estimate, Sales $666.20M Miss $690.28M Estimate

The Board of Directors of NewMarket Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) declared a quarterly dividend in the amount of $2.75 per share on the common stock of the Corporation, an increase of $0.25, or 10%, as compared to the last quarterly dividend of $2.50 per share. The dividend is payable April 1, 2025, to NewMarket shareholders of record at the close of business on March 17, 2025.

Dividends

NewMarket Corporation Increases Quarterly Dividend From $2.50 To $2.75 Per Share

Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.74) by 55.41 percent. This is a 55.41 percent increase over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $428.00 thousand which missed the analyst consensus estimate of $500.00 thousand by 14.40 percent. This is a 366.91 percent increase over sales of $91.67 thousand the same period last year.

WATT

Energous Q4 2024 Adj EPS $(0.33) Beats $(0.74) Estimate, Sales $428.00K Miss $500.00K Estimate

2025 Guidance
In December 2024, Pembina announced a 2025 adjusted EBITDA guidance range of $4.2 billion to $4.5 billion, which relative to 2024 reflects the impacts of continued volume growth across the WCSB, new assets acquired or placed into service, and the full year impact of the consolidation of the Alliance and Aux Sable assets, partially offset primarily by the full year impact of the recontracting of the Cochin Pipeline, and normalization of commodity margins in the marketing business.
Despite proposed tariffs on U.S. energy imports, Pembina does not expect any material near-term impacts given the highly contracted, take-or-pay nature of its business.
The 2025 adjusted EBITDA guidance range reflects quarterly seasonality in Pembina's business including:
<ul>
<li>higher contribution from Alliance in the first and fourth quarters due to the ability to transport higher volumes during colder periods;</li>
<li>higher integrity and geotechnical costs on the conventional pipeline assets in the third and fourth quarters; and</li>
<li>stronger first and fourth quarter results in the NGL marketing business.</li>
</ul>
Pembina continues to execute its strategy within a fully funded model and consistent with its financial guardrails. At December 31, 2024, the ratio of proportionately consolidated debt-to-adjusted EBITDA on a trailing twelve-month basis was 3.5 times, at the low end of the Company's targeted range, and reflecting only three quarters of contribution from the Alliance/Aux Sable Acquisition. Within the 2025 adjusted EBITDA guidance range, Pembina expects to generate positive free cash flow, with all 2025 capital investment program scenarios being fully funded by cash flow from operating activities, net of dividends. Further, the Company is forecasting a year-end 2025 proportionately consolidated debt-to-adjusted EBITDA ratio of 3.3 to 3.6 times.

Pembina Pipeline Sees FY25 Adj. EBITDA C$4.2B-C$4.5B

MasTec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.23 by 17.07 percent. This is a 118.18 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $3.40 billion which beat the analyst consensus estimate of $3.32 billion by 2.57 percent. This is a 3.75 percent increase over sales of $3.28 billion the same period last year.

MasTec Q4 2024 Adj EPS $1.44 Beats $1.23 Estimate, Sales $3.40B Beat $3.32B Estimate

Pembina Pipeline Q4 2024 GAAP EPS C$0.92 Beats C$0.82 Estimate, Sales C$2.145B Beats C$2.053B Estimate

It anticipates incurring total pre-tax restructuring charges of approximately $135 million to $150 million, a substantial majority of which would result in cash expenditures.&nbsp;

ADSK

Autodesk To Terminate Approximately 9% Of Its Workforce, Or Approximately 1,350 Employees

Bain Capital Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCSF#NYSE">BCSF</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 3.7 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $73.30 million which beat the analyst consensus estimate of $69.24 million by 5.87 percent. This is a 2.20 percent decrease over sales of $74.95 million the same period last year.

BCSF

Bain Capital Specialty Q4 GAAP EPS $0.52 Beats $0.48 Estimate, Sales $73.30M Beat $69.24M Estimate

American Healthcares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) is looking for FY2025 FFO of $1.56-$1.60 vs $1.59 analyst estimate..

American Healthcares Sees FY2025 FFO $1.56-$1.60 vs $1.59 Est

6 analysts have shared their evaluations of DT Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTM#NYSE">DTM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated DT Midstream and provided 12-month price targets. The average target is $107.33, accompanied by a high estimate of $115.00 and a low estimate of $94.00. Witnessing a positive shift, the current average has risen by 9.97% from the previous average price target of $97.60.
<img src="https://www.benzinga.com/files/images/story/2025/1740693689_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive DT Midstream. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Selman Akyol</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$102.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Jeremy Tonet</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$115.00</td>
<td>$109.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$112.00</td>
<td>-</td>
</tr>
<tr>
<td>Selman Akyol</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$106.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>John Mackay</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$94.00</td>
<td>$74.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to DT Midstream. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of DT Midstream compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for DT Midstream's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into DT Midstream's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DTM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on DT Midstream analyst ratings.</a>
<h2>Delving into DT Midstream's Background</h2>
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
<h3>A Deep Dive into DT Midstream's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining DT Midstream's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.98% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Energy sector.
Net Margin: DT Midstream's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 35.48% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): DT Midstream's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.09%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): DT Midstream's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.0%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.65, DT Midstream adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Expectations For DT Midstream's Future

Ratings for Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $164.89, a high estimate of $172.00, and a low estimate of $158.00. This upward trend is evident, with the current average reflecting a 1.47% increase from the previous average price target of $162.50.
<img src="https://www.benzinga.com/files/images/story/2025/1740693676_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Interparfums. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$168.00</td>
<td>$158.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$172.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Announces</td>
<td>Buy</td>
<td>$158.00</td>
<td>-</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$164.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Interparfums. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Interparfums compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Interparfums's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/IPAR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Interparfums analyst ratings.</a>
<h2>Unveiling the Story Behind Interparfums</h2>
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef &amp; Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
<h3>Interparfums's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Interparfums's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -14.87%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Interparfums's net margin is impressive, surpassing industry averages. With a net margin of 6.7%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Interparfums's ROE excels beyond industry benchmarks, reaching 3.18%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Interparfums's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.68%, the company showcases efficient use of assets and strong financial health.
Debt Management: Interparfums's debt-to-equity ratio is below the industry average. With a ratio of 0.26, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Vertical Aerospace

ニュース

最新ニュース Vertical Aerospace (NYSE:EVTL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル